Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

OBJECTIVES: To evaluate the potential prognostic utility of pretreatment systemic immune-inflammation index (SII) in newly diagnosed glioblastoma multiforme (GBM) patients who underwent postneurosurgical radiotherapy and concurrent plus adjuvant temozolomide. METHODS: The retrospective data of GBM p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mediators Inflamm
Main Authors: Topkan, Erkan, Besen, Ali Ayberk, Ozdemir, Yurday, Kucuk, Ahmet, Mertsoylu, Huseyin, Pehlivan, Berrin, Selek, Ugur
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262659/
https://ncbi.nlm.nih.gov/pubmed/32565725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4392189
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki